JUNE 13, 2019
We are both proud and humbled by our recently completed FDA Inspection encompassing 7 days with inspection of 6 quality systems to full GMP compliance. Having received the coveted ZERO observation/No 483 conclusion, we celebrate the validation of our hard work and commitment to quality and safety.
We do not take this honor lightly but rather as a challenge to continue to perform at a level of uncompromised excellence. Leadership, teamwork, professionalism, honesty, dedication, diligence, and persistence matter in the process of achieving a great success like this. Our team is focused on quality and assuring that all our products exceed expectations so that our customers and consumers can be certain that Allegiant Health brand products are at the pinnacle of the OTC/Supplement pyramid.
Throughout the inspection process, Allegiant’s commitment was evidenced by the investment in facility and equipment upgrades, laboratory performance and adherence to compendial requirements, staff training, in-depth investigational and complaint systems, and overall trustworthiness and integrity of the employees at Allegiant.
Our leadership could not be more proud to announce and celebrate this tremendous achievement.